Sleep Disorder Connect
  • Saved

1yr

Did you know?  Integrating mental health services into primary care can reduce depressive symptoms by 50% in patients with chronic conditions. Collaborative care models that involve care managers and primary care providers have proven effective in improving both mental and physical health outcomes.

Could a wider adoption of integrated mental health services revolutionize chronic disease management in primary care settings?

background

Could a wider adoption of integrated mental health services revolutionize chronic disease management in primary care settings?

  • Saved

1yr
infographicinfographic
  • Saved

1yr
Promising horizons in achondroplasia along with the development of new drugs

Promising horizons in achondroplasia along with the development of new drugs

Source : https://pubmed.ncbi.nlm.nih.gov/38569854/

Achondroplasia (ACH) is a representative skeletal disorder characterized by rhizomelic shortened limbs and short stature. ACH is classified as belonging to the fibroblast growth factor receptor 3 (FGFR3) group. The...

Achondroplasia (ACH) is a genetic skeletal disorder with short stature, severe complications, and emerging treatments like vosoritide, improving future prospects for patients.

  • Saved

1yr
Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa

Improved Sleep Correlates with Improved Quality of Life and Motor Symptoms with Foslevodopa/Foscarbidopa

Source : https://pubmed.ncbi.nlm.nih.gov/38465885/

Improved sleep with foslevodopa/foscarbidopa was associated with improved QoL and "Off" time.

Improved sleep with foslevodopa/foscarbidopa subcutaneous infusion in Parkinson's patients was positively associated with better quality of life, reduced "Off" time, and improved motor experiences of daily living.

  • Saved

2yr
Non-sleep related outcomes of maxillomandibular advancement, a systematic review

Non-sleep related outcomes of maxillomandibular advancement, a systematic review

Source : https://pubmed.ncbi.nlm.nih.gov/38503113/

Maxillomandibular advancement has been shown to be an effective treatment for obstructive sleep apnea; however, the literature focuses mainly on sleep-related parameters such as apnea-hypopnea index, respiratory disturbance index and...

Maxillomandibular advancement's non-sleep related outcomes lack standardized assessment, emphasizing the need for validated methods to evaluate patient satisfaction, esthetics, and functional results.